TY - JOUR
T1 - Ocular surface reconstruction by cultivated epithelial sheet transplantation
AU - Satake, Yoshiyuki
AU - Yamaguchi, Takefumi
AU - Hirayama, Masatoshi
AU - Higa, Kazunari
AU - Shimazaki-Den, Seika
AU - Dogru, Murat
AU - Kawakita, Tetsuya
AU - Kawashima, Motoko
AU - Shimmura, Shigeto
AU - Tsubota, Kazuo
AU - Shimazaki, Jun
N1 - Funding Information:
J. Shimazaki is a consultant to Otsuka Pharmaceutical Co, and has received payment for lecturing from Otsuka Pharmaceutical Co, Santen Pharmaceutical Co, and Alcon Japan. Y. Satake received a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (KAKENHI: 17791259); a grant from the Advanced and Innovational Research Program in Life Sciences of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for scientific research (C) from the Japan Society for the Promotion of Science (KAKENHI: 22591951); an Oral Health Science Center Grant hrc8 from Tokyo Dental College; and a grant from the Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, 2010 to 2012. M. Hirayama received funding from Keio University Research Grants for Life Science and Medicine, Keio University Medical Science Fund. J. Shimazaki received a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The other authors have no funding or conflicts of interest to disclose. The authors thank M. Aiba, F. Morito, and S. Yamaguchi for assisting with the culture procedures.
Funding Information:
J. Shimazaki is a consultant to Otsuka Pharmaceutical Co, and has received payment for lecturing from Otsuka Pharmaceutical Co, Santen Pharmaceutical Co, and Alcon Japan. Y. Satake received a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (JSPS) (KAKENHI: 17791259); a grant from the Advanced and Innovational Research Program in Life Sciences of the Ministry of Education, Culture, Sports, Science, and Technology, Japan; a Grant-in-Aid for scientific research (C) from the Japan Society for the Promotion of Science (KAKENHI: 22591951); an Oral Health Science Center Grant hrc8 from Tokyo Dental College; and a grant from the Project for Private Universities: matching fund subsidy from the Ministry of Education, Culture, Sports, Science, and Technology, Japan, 2010 to 2012. M. Hirayama received funding from Keio University Research Grants for Life Science and Medicine, Keio University Medical Science Fund. J. Shimazaki received a grant from the Ministry of Education, Culture, Sports, Science, and Technol-ogy, Japan. The other authors have no funding or conflicts of interest to disclose.
Publisher Copyright:
Copyright © 2014 by Lippincott Williams & Wilkins.
PY - 2014/11
Y1 - 2014/11
N2 - Recent advances in ocular surface reconstruction for patients with severe ocular surface diseases have significantly improved the prognosis of patients with vision-impairing corneal abnormalities. The history of cultivated epithelial sheet transplantation is short, and debate on the current approaches for these procedures is continuing. Limbal stem cell transplantation, including conjunctivolimbal autograft and keratolimbal allograft, has brought opportunities for vision improvement. In addition, the use of cultivated limbal epithelial transplantation from both allogeneic and autologous sources has provided further options for immediate postoperative epithelialization of the corneal surface. Finally, cultivated oral mucosal epithelial transplantation, which allows autologous transplantation for patients with bilateral limbal stem cell deficiency, has provided the best overall midterm and long-term results. Its biggest advantages are the absence of rejection reactions and the reduction of postoperative complications associated with steroid therapy. However, a solitary surgical approach is not sufficient for obtaining a good clinical outcome. To maximize the possibility of success using these procedures, it is important to preoperatively enhance aggressive treatment of the ocular surface, especially with factors that facilitate moisture retention. In this review article, we also discuss our clinical experience in relation to these surgical procedures.
AB - Recent advances in ocular surface reconstruction for patients with severe ocular surface diseases have significantly improved the prognosis of patients with vision-impairing corneal abnormalities. The history of cultivated epithelial sheet transplantation is short, and debate on the current approaches for these procedures is continuing. Limbal stem cell transplantation, including conjunctivolimbal autograft and keratolimbal allograft, has brought opportunities for vision improvement. In addition, the use of cultivated limbal epithelial transplantation from both allogeneic and autologous sources has provided further options for immediate postoperative epithelialization of the corneal surface. Finally, cultivated oral mucosal epithelial transplantation, which allows autologous transplantation for patients with bilateral limbal stem cell deficiency, has provided the best overall midterm and long-term results. Its biggest advantages are the absence of rejection reactions and the reduction of postoperative complications associated with steroid therapy. However, a solitary surgical approach is not sufficient for obtaining a good clinical outcome. To maximize the possibility of success using these procedures, it is important to preoperatively enhance aggressive treatment of the ocular surface, especially with factors that facilitate moisture retention. In this review article, we also discuss our clinical experience in relation to these surgical procedures.
KW - Epithelial sheet transplantation
KW - Keratoplasty
KW - Limbal stem cells
KW - Ocular surface reconstruction
UR - http://www.scopus.com/inward/record.url?scp=84929129742&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84929129742&partnerID=8YFLogxK
U2 - 10.1097/ICO.0000000000000242
DO - 10.1097/ICO.0000000000000242
M3 - Article
C2 - 25289723
AN - SCOPUS:84929129742
SN - 0277-3740
VL - 33
SP - S42-S46
JO - Cornea
JF - Cornea
ER -